Quick Answer
Tevogen Bio Holdings Inc. reported Shares Outstanding of 4.02 million shares for fiscal year 2025.
Tevogen Bio Holdings Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 4.02M | +12.9% |
| 2024 | 3.56M | +8.1% |
| 2024 | 3.29M | -97.3% |
| 2023 | 120.00M | +4935.6% |
| 2022 | 2.38M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 197.39M | +15.6% | +1.9% |
| June 30, 2025 | 193.69M | +14.7% | +5.3% |
| March 31, 2025 | 183.89M | +11.7% | +3.3% |
| December 31, 2024 | 177.99M | +48.3% | +4.2% |
| September 30, 2024 | 170.77M | — | +1.2% |
| June 30, 2024 | 168.83M | — | +2.6% |
| March 31, 2024 | 164.61M | — | +0.0% |
| January 31, 2024 | 164.61M | — | +37.2% |
- Tevogen Bio Holdings Inc. showed an increase of +12.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, Tevogen Bio Holdings Inc.’s shares outstanding has grown by 68.7% (from 2.38 million shares to 4.02 million shares).
- The most recent figure is from Tevogen Bio Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: